Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (13)	1/10/1997 10:03:00 PM
From: Boyce Burge	of 496

Ive recently read over GLFDs packet and looked at the H&Q summary recommendation on GLFD... In my opinion this is a SUPERB neuroscience co, and the stock is undervalued. For a mere $25/share you get Solomon Snyder's expertise (he owns 10%), gliadel revenues, the neurophylins, which are hopefully the answer to treating neurons... the big molecules dont seem to work... and the RPR partnership which should result in another big payment ($80 mil?) to GLFD in 1998. I sold my CEPH today ( it hit 25+ on the Regeneron news that their ALS drug has failed) and exchanged it for GLFD

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next